DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation

Bulletin Express07-28

Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for the six-month period ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend.

The notice, dated 28 July 2026, was issued by Chairman, Executive Director and General Manager Dr. Song Ning. As of the notice date, the Board comprises eight members: two executive directors (Dr. Song Ning and Mr. Weng Chih-Hsin), three non-executive directors (Dr. Xu Chen, Dr. Wu Lingqian and Mr. Yang Zehao) and three independent non-executive directors (Mr. Cha Yang, Ms. Zhang Jing and Mr. Wang Kaifeng).

No further financial figures or dividend details were provided in the announcement; those outcomes will be disclosed following the Board’s deliberations and subsequent publication of the interim results.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195122926?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195122926","market":"us","top_or_hot":-1,"title":"DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation","media":"Bulletin Express","content":"<p>Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for the six-month period ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend.</p>\n<p>The notice, dated 28 July 2026, was issued by Chairman, Executive Director and General Manager Dr. Song Ning. As of the notice date, the Board comprises eight members: two executive directors (Dr. Song Ning and Mr. Weng Chih-Hsin), three non-executive directors (Dr. Xu Chen, Dr. Wu Lingqian and Mr. Yang Zehao) and three independent non-executive directors (Mr. Cha Yang, Ms. Zhang Jing and Mr. Wang Kaifeng).</p>\n<p>No further financial figures or dividend details were provided in the announcement; those outcomes will be disclosed following the Board’s deliberations and subsequent publication of the interim results.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDIAGENS-B to Convene Board Meeting on 7 Aug 2026 for Interim Results and Dividend Deliberation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-28 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for the six-month period ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend.</p>\n<p>The notice, dated 28 July 2026, was issued by Chairman, Executive Director and General Manager Dr. Song Ning. As of the notice date, the Board comprises eight members: two executive directors (Dr. Song Ning and Mr. Weng Chih-Hsin), three non-executive directors (Dr. Xu Chen, Dr. Wu Lingqian and Mr. Yang Zehao) and three independent non-executive directors (Mr. Cha Yang, Ms. Zhang Jing and Mr. Wang Kaifeng).</p>\n<p>No further financial figures or dividend details were provided in the announcement; those outcomes will be disclosed following the Board’s deliberations and subsequent publication of the interim results.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02526","symbol_name":"德适-B","start_time":0,"source_url":"","article_id":"1195122926","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195122926","pubTimestamp":1785229551,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02526":"德适-B"},"translate_title":"DIAGENS-B 将于 2026 年 8 月 7 日召开董事会会议，讨论中期业绩和股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02526":1},"content_text":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced that its board of directors will meet on 7 August 2026 in Hangzhou to review and approve the Group’s interim financial results for the six-month period ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend.\nThe notice, dated 28 July 2026, was issued by Chairman, Executive Director and General Manager Dr. Song Ning. As of the notice date, the Board comprises eight members: two executive directors (Dr. Song Ning and Mr. Weng Chih-Hsin), three non-executive directors (Dr. Xu Chen, Dr. Wu Lingqian and Mr. Yang Zehao) and three independent non-executive directors (Mr. Cha Yang, Ms. Zhang Jing and Mr. Wang Kaifeng).\nNo further financial figures or dividend details were provided in the announcement; those outcomes will be disclosed following the Board’s deliberations and subsequent publication of the interim results.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195122926","isCrawlerRequest":true}